Patricia K Dranchak

age ~47

from Gaithersburg, MD

Also known as:
  • Patric Dranchak
  • Patricaia Dranchak
  • Steven Bushey
  • Steve Bushey
  • Zachary Hall
  • Ramsook Jennel
  • Jennel Sinclair
Phone and address:
102 George St, Gaithersburg, MD 20877
3019909649

Patricia Dranchak Phones & Addresses

  • 102 George St, Gaithersburg, MD 20877 • 3019909649
  • 205 Lee St, Gaithersburg, MD 20877 • 2404776343
  • s
  • 205 Lee St APT 307, Gaithersburg, MD 20877 • 2404776343
  • Fridley, MN
  • Germantown, MD
  • Pasadena, CA
  • Saint Paul, MN
  • Champlin, MN
  • Bainbridge, NY
  • Elmira, NY

Us Patents

  • Compositions And Methods For The Inhibition Of Pruritus

    view source
  • US Patent:
    20210145800, May 20, 2021
  • Filed:
    Nov 2, 2018
  • Appl. No.:
    16/761047
  • Inventors:
    - Bethesda MD, US
    Hans Juergen Solinski - Pr. Oldendorf, DE
    James Inglese - Bethesda MD, US
    Patricia Dranchak - Gaithersburg MD, US
  • Assignee:
    The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
  • International Classification:
    A61K 31/422
    A61K 31/5513
    A61K 31/55
    A61K 31/506
    A61K 31/4545
    A61K 31/4439
    A61K 31/497
    A61K 31/395
    A61P 17/04
  • Abstract:
    Pharmaceutical compositions comprising a molecular inhibitor of Npr1 are disclosed. Also disclosed are methods of treating, reducing, or preventing acute and/or chronic pruritus in a mammal comprising administering a pharmaceutical composition comprising a molecular inhibitor of Npr1.
  • Compositions And Methods For The Treatment Of Zellweger Spectrum Disorder

    view source
  • US Patent:
    20200046693, Feb 13, 2020
  • Filed:
    May 20, 2019
  • Appl. No.:
    16/417167
  • Inventors:
    Joseph Hacia - Los Angeles CA, US
    Nancy E. Braverman - Los Angeles CA, US
    Patricia Dranchak - Los Angeles CA, US
    James Inglese - Los Angeles CA, US
  • International Classification:
    A61K 31/485
    C12Q 1/6883
  • Abstract:
    Provided herein are methods of treating Zellweger spectrum disorder (ZSD) in a subject in need thereof or improving peroxisome assembly in a cell in need thereof comprising administering to the subject a therapeutically effective amount of Compounds of Formula I or II.
  • Method Of Identifying A Compound Which Affects The Multienzyme Metabolic Assembly Of Glucose Metabolism And Its Association With Cell Cycle Progression In Cancer Cells

    view source
  • US Patent:
    20190391135, Dec 26, 2019
  • Filed:
    Jun 26, 2019
  • Appl. No.:
    16/452767
  • Inventors:
    - Baltimore MD, US
    Danielle L. SCHMITT - San Diego CA, US
    James INGLESE - Bethesda MD, US
    Patricia DRANCHAK - Gaithersburg MD, US
  • International Classification:
    G01N 33/50
    C12N 15/85
    G01N 21/64
  • Abstract:
    A cell-based quantitative high-throughput screening assay to monitor the formation of PFK1-mEGFP clusters by the action of small molecules to identify small molecules that promote intracellular PFK1 clustering in a cell cycle-dependent manner and may be used to treat cancer.
  • Benzenesulfonamide Upregulators Of Npc1 For Neimann-Pick Disease And Other Lysosomal Storage Disorders

    view source
  • US Patent:
    20180044286, Feb 15, 2018
  • Filed:
    Feb 11, 2016
  • Appl. No.:
    15/549743
  • Inventors:
    - New York NY, US
    - Rockville MD, US
    Raul Rolando CALVO - Rockville MD, US
    Juan Jose MARUGAN - Rockville MD, US
    Noel SOUTHALL - Rockville MD, US
    Wei ZHENG - Rockville MD, US
    Patricia DRANCHAK - Rockville MD, US
    Fannie CHEN - New York NY, US
    Yiannis IOANNOU - New York NY, US
  • Assignee:
    ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI - New York NY
    and Human Services - Rockville MD
  • International Classification:
    C07C 311/21
    C07D 207/335
    C07D 213/46
    C07D 233/64
  • Abstract:
    Methods and compositions for treating lysosomal storage disorders are disclosed. The methods involve administering a genus of benzenesulfonamides, particularly N-[3-(aminosulfonyl)phenyl]-benzamides and heteroarylamides. A genus of suitable compounds is shown in formula 1:
  • Compositions And Methods For The Treatment Of Zellweger Spectrum Disorder

    view source
  • US Patent:
    20180000814, Jan 4, 2018
  • Filed:
    Jun 14, 2017
  • Appl. No.:
    15/623333
  • Inventors:
    Joseph Hacia - Los Angeles CA, US
    Nancy E. Braverman - Los Angeles CA, US
    Patricia Dranchak - Los Angeles CA, US
    James Inglese - Los Angeles CA, US
  • International Classification:
    A61K 31/485
    C12Q 1/68
  • Abstract:
    Provided herein are methods of treating Zellweger spectrum disorder (ZSD) in a subject in need thereof or improving peroxisome assembly in a cell in need thereof comprising administering to the subject a therapeutically effective amount of Compounds of Formula I or II.

Facebook

Patricia Dranchak Photo 1

Patricia Dranchak Carls

view source
Patricia Dranchak Carlson
Patricia Dranchak Photo 2

Patricia Dranchak

view source

Get Report for Patricia K Dranchak from Gaithersburg, MD, age ~47
Control profile